Related Experiment Video
Updated: Jul 15, 2026

07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Novel insights in dopamine receptor physiology
European Journal of Endocrinology
|April 7, 2007
Summary
The dopaminergic system, using dopamine receptors D(1)-D(5), regulates the central nervous system and endocrine functions. This review explores dopamine receptor roles in the hypothalamus-pituitary-adrenal axis and neuroendocrine tumors.
Area of Science:
- Neuroendocrinology
- Molecular Pharmacology
Background:
- The dopaminergic system is crucial for central nervous system function and peripheral endocrine regulation.
- Dopamine receptors (D1-D5) are G protein-coupled receptors involved in diverse physiological processes.
Purpose of the Study:
- To review the structural and functional characteristics of dopamine receptors.
- To focus on the dopaminergic system's regulation of the hypothalamus-pituitary-adrenal axis.
- To summarize recent findings on dopamine receptors in endocrine and neuroendocrine tumors.
Main Methods:
- Literature review of structural and functional characteristics of dopamine receptors.
- Analysis of studies on dopamine receptor expression and function in endocrine systems.
- Synthesis of research on dopamine receptors in the hypothalamus-pituitary-adrenal axis and related tumors.
Main Results:
- Dopamine receptors are expressed in various tissues, influencing neurotransmission and hormone secretion.
- The dopaminergic system significantly regulates the hypothalamus-pituitary-adrenal axis.
- Dopamine receptors are found in endocrine and neuroendocrine tumors, suggesting a role in tumorigenesis.
Conclusions:
- Dopamine receptors play a vital role in the physiological and pathological regulation of the endocrine system.
- Further research into dopamine receptors in neuroendocrine tumors may reveal therapeutic targets.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...

